PALB2 is known to regulate BRCA2 to DSB, and BRCA2 is essential for RAD51 recruitment to form nucleprotein filament.
PALB2 is known as FANC-N, Fanconi anaemia subtype N
130 kDa
No clear functional domain other than predicted amino-terminal coiled coil structure and a carboxy-terminal WD40 repeat motif.
The WD40 forms a 7 blades on PALB2 C-terminus as a ring structure. Y1183X mutation loses some C-terminal residues that inhibits the closure of the WD40 ring and destabilize PALB2 protein.
PALB2 N-terminus was thought to bind to BRCA1 to help recognize the DSB. Then, The N-terminus of BRCA2 protein interacts with PALB2 at its bottom pocket formed by the 4th and 5th blades and also interacts with EMSY protein at exactly at the same sequence. [EMSY is highly amplified and expressed in breast and ovarian cancers]. So in cancerous cells, EMSY may outcompete PALB2 at the binding site on BRCA2 to disturb the HR-mediated DNA repair.
[How???? Does BRCA2 compete with BRCA1 when BRCA1-PALB2 recognize the DSB???? or they bind at different sites or they just bind PALB2 at different stages during HR???]. BRCA2 interacts with RAD51 via the BRC repeat in the BRCA2 C-terminus. [So BRCA2-PALB2 complex is formed at the DSB to attract RAD51 over bc BRCA2 is scaffolding protein, so how does BRCA2-PALB2 complex signal for RAD51 to come to damage sites????] This BRCA2 C-terminal binding domain can revert mutant BRCA2 protein's internal deletion to restore HR.
No comments:
Post a Comment